Evidence map›Paper›PMID 23418877›Full record

Trial reportBJOG : an international journal of obstetrics and gynaecology2013

Near-infrared fluorescence sentinel lymph node biopsy in vulvar cancer: a randomised comparison of lymphatic tracers.

B E Schaafsma, F P R Verbeek, A A W Peters, J R van der Vorst, C D de Kroon, M I E van Poelgeest, J B M Z Trimbos, C J H van de Velde, J V Frangioni, A L Vahrmeijer and 1 more

Abstract readRandomized Controlled Trial
In one paragraph

Trial report in BJOG : an international journal of obstetrics and gynaecology, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed, 4 pooled it
7.5field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 4 syntheses or guidelines pooled it, 73 citations in OpenAlex.

  1. Pooled it
  2. Detection of sentinel lymph node in vulvar cancer usingArchives of gynecology and obstetrics · 2023
    Pooled it
  3. Pooled it
  4. Pooled it
  5. Review
  6. Article
  7. Update on near infrared imaging technology: indocyanine green and near infrared technology in the treatment of gynecologic cancers.International journal of gynecological cancer : official journal of the International Gynecological Cancer Society · 2024
    Review
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Review
  14. Review
  15. Article
  16. Current and novel mapping substances in gynecologic cancer care.International journal of gynecological cancer : official journal of the International Gynecological Cancer Society · 2020
    Review
  17. Vulvar malignancies: an interdisciplinary perspective.Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG · 2019
    Review
  18. Article
  19. Role of ICG-European journal of nuclear medicine and molecular imaging · 2017
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 2 countries.

B E SchaafsmaDepartment of Surgery, Leiden University Medical Centre, Leiden, the Netherlands.
F P R Verbeek
A A W Peters
J R van der Vorst
C D de Kroon
M I E van Poelgeest
J B M Z Trimbos
C J H van de Velde
J V Frangioni
A L Vahrmeijer
K N Gaarenstroom
Leiden University · NLLeiden University Medical Center · NLBeth Israel Deaconess Medical Center · US

Funding

Intraoperative Near-Infrared Fluorescence ImagingR01CA115296 · NCI · CURADEL, LLC · PI FRANGIONI, JOHN V · 2005 to 2014
$13.9M
NIR Fluorescent SLN Mapping for Breast CancerR21CA130297 · NCI · BETH ISRAEL DEACONESS MEDICAL CENTER · PI FRANGIONI, JOHN V · 2008 to 2009
$765k
NCI NIH HHS R01 CA115296NCI NIH HHS R01-CA-115296NCI NIH HHS R21 CA130297NCI NIH HHS R21-CA-130297
6 · The paper itself

Abstract

This study aims to confirm the feasibility of near-infrared (NIR) fluorescence imaging for sentinel lymph node (SLN) biopsy in vulvar cancer and to compare the tracer indocyanine green (ICG) bound to human serum albumin (HSA) versus ICG alone. Women received 99mTc-nanocolloid and patent blue for SLN detection. Subsequently, women randomly received ICG:HSA or ICG alone. In 24 women, 35 SLNs were intraoperatively detected. All SLNs detected were radioactive and NIR fluorescent and 27 (77%) were blue. No significant difference was found between ICG:HSA and ICG alone. This trial confirms the feasibility of NIR fluorescence imaging for SLN mapping in vulvar cancer.

Indexed as

Indocyanine GreenAdultAgedAged, 80 and overAlbuminsDouble-Blind MethodFeasibility StudiesFemaleFluorescenceHumansImage-Guided BiopsyLymph NodesMiddle AgedSentinel Lymph Node BiopsySpectroscopy, Near-InfraredVulvar NeoplasmsAlbuminsIndocyanine Green

Identifiers

PMID23418877
PMCPMC3622799
OpenAlexW2082405891

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.